Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
(applications tested for the base form of this product only)
DGCR2 antibody was raised against synthetic peptide from N-Terminus of human DGCR2 (P98153, NP_005128). Percent identity by BLAST analysis: Human, Chimpanzee, Orangutan, Marmoset, Mouse, Rat, Elephant, Bovine, Bat, Pig, Guinea pig (100%); Opossum, Xenopus (92%); Zebra finch, Chicken (85%).
The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested.
100 mM sodium phosphate, pH 7.6, 150 mM NaCl
Short term: store at 4°C. Long term: add glycerol to 40-50%, aliquot to avoid freeze-thaw cycles, and store at -20°C. Protect from light.
Deletions of the 22q11.2 have been associated with a wide range of developmental defects (notably DiGeorge syndrome, velocardiofacial syndrome, conotruncal anomaly face syndrome and isolated conotruncal cardiac defects) classified under the acronym CATCH 22. The DGCR2 gene encodes a novel putative adhesion receptor protein, which could play a role in neural crest cells migration, a process which has been proposed to be altered in DiGeorge syndrome.